Tien Liang BioTech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	511.79	385.21	459.99	528.52	571.32
Revenue Growth (YoY)	32.86%	-16.26%	-12.97%	-7.49%	32.53%
Cost of Revenue	223.86	155.29	173.85	191.98	233.04
Gross Profit	287.94	229.91	286.15	336.55	338.28
Selling, General & Admin	299.5	226.84	266	276.86	294.14
Research & Development	4.58	2.48	1.28	1.4	1.2
Operating Expenses	304.08	229.32	267.27	278.26	295.33
Operating Income	-16.14	0.59	18.87	58.29	42.95
Interest Expense	-11.13	-3.08	-2.08	-1.77	-1.85
Interest & Investment Income	25.58	4.83	0.6	0.14	0.03
Currency Exchange Gain (Loss)	-9.89	6.16	0.1	-0.45	-0.06
Other Non Operating Income (Expenses)	-0.22	2.35	0.35	3.09	7.71
EBT Excluding Unusual Items	-11.8	10.84	17.84	59.3	48.78
Gain (Loss) on Sale of Investments	-	2.93	-	-	-
Gain (Loss) on Sale of Assets	0.05	-0.68	0.57	0.03	-
Pretax Income	-11.75	13.1	18.42	59.33	48.78
Income Tax Expense	-1.5	1.4	0.68	-0.15	2.18
Earnings From Continuing Operations	-10.25	11.7	17.73	59.48	46.61
Net Income	-10.25	11.7	17.73	59.48	46.61
Net Income to Common	-10.25	11.7	17.73	59.48	46.61
Net Income Growth	-	-34.04%	-70.19%	27.63%	-
Shares Outstanding (Basic)	46	46	46	46	46
Shares Outstanding (Diluted)	46	46	46	46	46
Shares Change (YoY)	-0.01%	-0.04%	0.01%	0.05%	-
EPS (Basic)	-0.22	0.26	0.39	1.30	1.02
EPS (Diluted)	-0.22	0.26	0.39	1.30	1.02
EPS Growth	-	-34.04%	-70.19%	27.63%	-
Free Cash Flow	-3.96	44.61	64.71	20.87	44.61
Free Cash Flow Per Share	-0.09	0.97	1.41	0.46	0.97
Dividend Per Share	-	-	0.500	-	-
Gross Margin	56.26%	59.69%	62.21%	63.68%	59.21%
Operating Margin	-3.15%	0.15%	4.10%	11.03%	7.52%
Profit Margin	-2.00%	3.04%	3.85%	11.25%	8.16%
Free Cash Flow Margin	-0.77%	11.58%	14.07%	3.95%	7.81%
EBITDA	-6.58	9.25	28.82	68.28	54.15
EBITDA Margin	-1.29%	2.40%	6.26%	12.92%	9.48%
D&A For EBITDA	9.57	8.66	9.94	10	11.21
EBIT	-16.14	0.59	18.87	58.29	42.95
EBIT Margin	-3.15%	0.15%	4.10%	11.03%	7.52%
Effective Tax Rate	-	10.70%	3.71%	-	4.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.